V017-5756 Screening compound: N-[5-(3-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-2-(naphthalene-1-sulfonamido)-3-phenylpropanamide

V017-5756 Screening compound: N-[5-(3-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-2-(naphthalene-1-sulfonamido)-3-phenylpropanamide
V017-5756 Screening compound: N-[5-(3-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-2-(naphthalene-1-sulfonamido)-3-phenylpropanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V017-5756
N-[5-(3-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-2-(naphthalene-1-sulfonamido)-3-phenylpropanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V017-5756

Molecular Formula

C28H24N4O4S2 (C28 H24 N4 O4 S2)

Compound Name

N-[5-(3-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-2-(naphthalene-1-sulfonamido)-3-phenylpropanamide

IUPAC name

N-[5-(3-methoxyphenyl)-134-thiadiazol-2-yl]-2-(naphthalene-1-sulfonamido)-3-phenylpropanamide

SMILES

COc1cccc(-c2nnc(NC(C(Cc3ccccc3)NS(c3cccc4ccccc34)(=O)=O)=O)s2)c1

InChI

InChI=1S/C28H24N4O4S2/c1-36-22-14-7-13-21(18-22)27-30-31-28(37-27)29-26(33)24(17-19-9-3-2-4-10-19)32-38(34,35)25-16-8-12-20-11-5-6-15-23(20)25/h2-16,18,24,32H,17H2,1H3,(H,29,31,33)/t24-/m0/s1

InChI Key

BVNHDAZOOIXTBH-DEOSSOPVSA-N

MDL Number (MFCD)

MFCD14242161

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

544.66

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.815

Distribution Coefficient, logD

5.809

Water Solubility, LogSw

-6.74

Polar Surface Area

95.477

Acid Dissociation Constant (pKa)

9.26

Base Dissociation Constant (pKb)

-3.96

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

10.70

V017-5756 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Others
  • Proteases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V017-5756 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V017-5756?
Check Price and Availability of V017-5756, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V017-5756 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V017-5756
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V017-5756
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V017-5756 available by request